Prudential Financial’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.2K	Buy	+16,095	New	+$28.6K	﹤0.01%	2370
2025 Q4	–	Sell	-14,980	Closed	-$24.6K	–	2253
2025 Q3	$24.6K	Hold	14,980	–	–	﹤0.01%	2391
2025 Q2	$10.9K	Buy	+14,980	New	+$12.9K	﹤0.01%	2420
2023 Q3	–	Sell	-82,529	Closed	-$352K	–	2609
2023 Q2	$352K	Buy	82,529 +19,642	+31%	+$116K	﹤0.01%	2246
2023 Q1	$430K	Sell	62,887 -2,800	-4%	-$21.7K	﹤0.01%	2140
2022 Q4	$520K	Buy	65,687 +55	+0.1%	+$423	﹤0.01%	2005
2022 Q3	$631K	Sell	65,632 -500	-0.8%	-$5.06K	﹤0.01%	1966
2022 Q2	$479K	Sell	66,132 -560	-0.8%	-$4.87K	﹤0.01%	2156
2022 Q1	$861K	Sell	66,692 -1,823	-3%	-$23.2K	﹤0.01%	1941
2021 Q4	$1.21M	Sell	68,515 -1,369	-2%	-$23.9K	﹤0.01%	1792
2021 Q3	$1.23M	Sell	69,884 -4,258	-6%	-$62.4K	﹤0.01%	1697
2021 Q2	$1.02M	Sell	74,142 -74,804	-50%	-$1.06M	﹤0.01%	1823
2021 Q1	$2.18M	Sell	148,946 -102,510	-41%	-$1.74M	﹤0.01%	1420
2020 Q4	$4.37M	Buy	251,456 +41,764	+20%	+$744K	0.01%	1063
2020 Q3	$3.85M	Buy	209,692 +135,786	+184%	+$2.53M	0.01%	1023
2020 Q2	$1.32M	Buy	+73,906	New	+$1.25M	﹤0.01%	1518